Related Experiment Video
Updated: Mar 22, 2026

Rose Bengal-Mediated Photodynamic Therapy to Inhibit Candida albicans
Published on: March 24, 2022
Serratia marcescens resistance profile and its susceptibility to photodynamic antimicrobial chemotherapy
Ticiana Mont Alverne Lopes Parente1, Emanuela de Lima Rebouças1, Vitor Coutinho Vieira Dos Santos2
1Biotechnology Post-Graduate Program, Federal University of Ceara, Comandante Mauricélio, Rocha Pontes Street, 100, Sobral, CE 62.042-280 Brazil.
Background:
Some authors have reported the antimicrobial action of photodynamic antimicrobial chemotherapy (PACT) on bacteria related to nosocomial infections but there are few studies evaluating PACT on Serratia marcescens grown as planktonic cultures or as biofilms. The purpose of this study was to analyze the S. marcescens resistance profile and its susceptibility to PACT.
Methods:
Initially, 55 S. marcescens strains isolated from environmental, oral and extra-oral infections were tested by antimicrobial resistance to cefotaxime (CTX), imipenem (IPM), ciprofloxacin (CIP), tobramycin (TOB) and doxycycline (DOX) using E-test(®). Following, isolates grown as planktonic cultures or biofilms were submitted to PACT using the association of a light-emitting diode and toluidine blue (TBO). The E-test(®) results demonstrated intermediated sensitive strains to CTX, IMP, TOB, and DOX; and resistant strains to CTX, TOB, DOX and CIP. Also, CTX and IMP demonstrated variation when CLSI 2007 and CLSI 2015 were compared.
Results:
Planktonic cultures and biofilms submitted to PACT demonstrated counts varying from 10(11) to 10(7) for planktonic cultures and 10(10) to 10(7) for biofilms. There were no statistical differences in the results when planktonic cultures and biofilms were compared.
Conclusions:
Increase in the profile of S. marcescens resistance was observed when CLSI 2007 and CLSI 2015 were compared. Also, IMP remains as the drug with lower rate of resistance. Additionally, both S. marcescens planktonic cultures and early biofilms are susceptible to PACT under tested conditions.
Insights
Photodynamic antimicrobial chemotherapy (PACT) effectively targets both planktonic Serratia marcescens and biofilms. This study highlights increasing resistance to common antibiotics, underscoring PACT
Area of Science:
- Antimicrobial chemotherapy
- Microbiology
- Infectious diseases
Background:
- Limited studies evaluate photodynamic antimicrobial chemotherapy (PACT) efficacy against Serratia marcescens.
- PACT's effectiveness on planktonic cultures and biofilms of S. marcescens requires further investigation.
- Nosocomial infections caused by S. marcescens necessitate novel treatment strategies.
Purpose of the Study:
- To assess the antibiotic resistance profile of Serratia marcescens.
- To determine the susceptibility of S. marcescens planktonic cultures and biofilms to PACT.
- To compare antibiotic resistance patterns using CLSI 2007 and CLSI 2015 guidelines.
Main Methods:
- Antimicrobial susceptibility testing of 55 S. marcescens strains using E-test® against cefotaxime, imipenem, ciprofloxacin, tobramycin, and doxycycline.
- Application of PACT using a light-emitting diode and toluidine blue (TBO) on planktonic cultures and biofilms.
- Analysis of resistance data comparing Clinical and Laboratory Standards Institute (CLSI) 2007 and 2015 guidelines.
Main Results:
- S. marcescens exhibited intermediate sensitivity to cefotaxime, imipenem, tobramycin, and doxycycline, with resistance to cefotaxime, tobramycin, doxycycline, and ciprofloxacin.
- A notable increase in S. marcescens resistance was observed between CLSI 2007 and CLSI 2015 standards.
- PACT demonstrated significant bacterial reduction in both planktonic cultures (10^11 to 10^7) and biofilms (10^10 to 10^7) without statistical difference.
- Imipenem showed the lowest resistance rate among the tested antibiotics.
Conclusions:
- Serratia marcescens demonstrates evolving resistance to common antibiotics, with imipenem remaining a more effective agent.
- Photodynamic antimicrobial chemotherapy (PACT) is a viable treatment option for both planktonic S. marcescens and early-stage biofilms.
- The findings support PACT as a promising therapeutic strategy against S. marcescens infections, including those in biofilm states.
More Related Videos
05:57The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing